ZEMIDAPA is a combination of gemigliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor and dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes(T2D) patients for whom coadministration of gemigliptin and dapagliflozin is appropriate.
DOSAGE AND ADMINISTRATION
The recommended dose of ZEMIDAPA is a 10 mg dapagliflozin/50 mg gemigliptin tablet taken orally once daily, with or without food.
Special Group Renal Impairment The efficacy and safety of this drug depend on renal function, and it is recommended to periodically assess renal function before and after administration of this drug. - No dose adjustment is required if the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73 m2 or higher. - Administration of this drug is not recommended if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. Hepatic Impairment No dose adjustment is required in patients with mild to moderate hepatic impairment. The safety and efficacy of this drug have not been studied in patients with severe hepatic impairment.
Appearance and Packaging Unit 56 tablets/box [(14 tablets/PTP)x4]
Active Ingredient and Capacity Gemigliptin/Dapagliflozin: 50/10 mg
Storage / Shelf Life Store in a tight container at room temperature (1 to 30°C) 36 months from the date of manufacturing
When you visit our website, information is stored in your browser or exported in the form of cookies. This information may be about you, your preferences, or the device you use, and is most often used to ensure that the website works properly. This information does not identify you directly, but it can offer a more optimized experience as you navigate our website. Because we respect your right to privacy, you may choose not to allow certain types of cookies. You can check the detailed settings and change them according to your needs.
This website uses technical cookies that are essential for using all of its features. They perform specific functions required to ensure your normal navigation of the site.
- Amazon Web Service
- Web Application Server
- Identifies whether the user checked "Do not see again today" in the pop-up window on the main page of the site
- Identifies whether the user participated in customer surveys
These cookies collect information about how visitors use the website to help improve the site. For example, we anonymously collect information such as the visitor’s device, access area, and time of visit.
These cookies balance the server load and maintain user sessions.
AWSALB, AWSALBCORS, AWSALBTG, AWSALBTGCORS
Browser type, browser version, operating system, authentication and security credentials, links inserted in e-mails viewed or clicked through AWS, device type, time and number of livestreams and downloads, Internet service provider, time zone, network connection type, device information, geolocation, playback details, page response time, content downloaded from AWS, download error, page interaction, content interaction, interaction or communication with AWS, browser plug-ins, cookies, cookie ID, mouse movement, click paths, phone number, content and ad views and interactions, usage data, IP address, accessed applications, full URL clickstream (including date and time) from or through the AWS website, streams, number of visits and interactions with AWS offerings
AWSALB, AWSALBCORS, AWSALBTG : 6 days AWSALBTGCORS : 7 days
Recipients of data
Amazon Web Services Inc., Amazon Web Services EMEA SARL